1-3 of 3
Sara Nik
Close
Sort by
Journal Articles

Pre-Clinical Development of a Highly Efficient TALEN ® -Based Correction of the β-Globin Gene in Patient-Derived Hematopoietic Stem and Progenitor Cells (HSPCs) to Treat Sickle Cell Disease

Arianna Moiani, Patrick Hong, Gil Letort, Sabrina Lizot, Alexa Chirinos, Sonal Temburni-Blake, Sara Nik, Louisa Mayer, Sophie Leduc, Noemie Pinard, Chloe Foray, Alex Boyne, Selena Kazancioglu, Giacomo Frati, Tristan Felix, Anne Chalumeau, Annarita Miccio, Mathilde Dusseaux, Agnès Gouble, Mark G. Frattini, Carrie Brownstein, Aymeric Duclert, Cecile Shiffer-Mannoui, Alexandre Juillerat, Philippe Duchateau, Julien Valton
Journal: Blood
Blood (2021) 138 (Supplement 1): 1856.
https://doi.org/10.1182/blood-2021-153549
Published: 2021
Journal Articles

A Chemical Modifier Screen in Zebrafish Mutants for the Spliceosomal Component Sf3b1reveals Genotype-Selective Vulnerabilities

Rosannah C. Cameron, PhD, Mia McKinstry, Adriana De La Garza, Sara Nik, Peter G Smith, PhD, Silvia Buonamici, PhD, Robert K. Bradley, PhD, Teresa V. Bowman, PhD
Journal: Blood
Blood (2016) 128 (22): 965.
https://doi.org/10.1182/blood.V128.22.965.965
Published: 2016
Journal Articles

The Spliceosomal Component Sf3b1 Is Essential for Hematopoietic Differentiation

Adriana De La Garza-Sauceda, Rosannah C. Cameron, PhD, Sara Nik, Michelle Gulfo, Sara G. Payne, Teresa V. Bowman, PhD
Journal: Blood
Blood (2015) 126 (23): 3582.
https://doi.org/10.1182/blood.V126.23.3582.3582
Published: 2015